FDA Workshop on the Development of Antibiotic Therapies for NTM

On April 8th, 2019 from 8:30 am to 5 pm the FDA will hold a public workshop entitled “Development of Antibacterial Drugs for the Treatment of Nontuberculous Mycobacterial Disease.” The purpose of the public workshop is to discuss the clinical trial design considerations, including endpoints, related to the development of antibacterial drug products for treatment of nontuberculous mycobacterial (NTM) disease.

The workshop will be held at FDA’s White Oak campus, 10903 New Hampshire Ave., Building 31 Great Room, Silver Spring, MD 20993. You may register to attend in person or view the live stream webcast. Click here to register for in person or online attendance.

At this workshop, we will present the results of our survey on Patient Preferences in Clinical Trials & Treatment Outcomes. If you haven’t taken the survey yet, please click here to take it now and help us convey your wishes to the FDA and industry.